{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:14:04Z","timestamp":1781118844948,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopha.2023.114633","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:59:39Z","timestamp":1680501579000},"page":"114633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synergistic anti-cancer and attenuation effects of thymosin on chemotherapeutic drug vinorelbine in tumor-bearing zebrafish"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3533-8565","authenticated-orcid":false,"given":"Shuai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2023.114633_bib1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1200\/JCO.20.01820","article-title":"Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: final overall survival analysis of CTONG1104 phase III trial","volume":"39","author":"Zhong","year":"2021","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114633_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.21.01729","article-title":"Randomized phase III study of gefitinib versus cisplatin plus vinorelbine for patients with resected stage II-IIIA non-small-cell lung cancer with EGFR mutation (IMPACT)","volume":"40","author":"Tada","year":"2022","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114633_bib3","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00280-014-2595-5","article-title":"Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer","volume":"74","author":"Sonobe","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114633_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1078155217724595","article-title":"Effectiveness of adjuvant carboplatin-based chemotherapy compared to cisplatin in non-small cell lung cancer","volume":"25","author":"Couillard-Montminy","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.biopha.2023.114633_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lungcan.2020.05.001","article-title":"Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: a single-center experience","volume":"145","author":"Rossi","year":"2020","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2023.114633_bib6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/14737140.2018.1518714","article-title":"Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review","volume":"18","author":"Lesueur","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.biopha.2023.114633_bib7","article-title":"The efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitor combined with thymosin in advanced non-small cell lung cancer patients harboring active epidermal growth factor receptor mutations","volume":"11","author":"Feng","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114633_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/bbb\/zbaa113","article-title":"PTEN\/AKT upregulation of TMSB10 contributes to lung cancer cell growth and predicts poor survival of the patients","volume":"85","author":"Li","year":"2021","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.biopha.2023.114633_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1979.tb47095.x","article-title":"Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation","volume":"332","author":"Low","year":"1979","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"13\u201314","key":"10.1016\/j.biopha.2023.114633_bib10","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/0959-8049(95)00477-7","article-title":"Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a","author":"Garaci","year":"1995","journal-title":"Eur. J. Cancer 31a("},{"key":"10.1016\/j.biopha.2023.114633_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fonc.2019.00873","article-title":"of Thymosin Alpha1 in Cancer Therapy","volume":"9","author":"Costantini","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2023.114633_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34030-5","article-title":"Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model","volume":"8","author":"Jin","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.114633_bib13","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2147\/DDDT.S145956","article-title":"Murrangatin suppresses angiogenesis induced by tumor cell-derived media and inhibits AKT activation in zebrafish and endothelial cells","volume":"12","author":"Long","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.114633_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.clpt.6100223","article-title":"Zebrafish: an emerging model system for human disease and drug discovery","volume":"82","author":"Kari","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"issue":"16","key":"10.1016\/j.biopha.2023.114633_bib15","article-title":"Jensen, Zebrafish patient tumor-derived xenograft models used for preclinical evaluation of CAN04 for lung and pancreatic cancer","volume":"80","author":"Ali","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.114633_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s13046-021-02173-5","article-title":"Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis","volume":"40","author":"Fan","year":"2021","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"8","key":"10.1016\/j.biopha.2023.114633_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.trecan.2021.06.006","article-title":"Zebrafish as a new model to study the crosstalk between tumor and host metabolism","volume":"7","author":"Montal","year":"2021","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2023.114633_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-020-01460-z","article-title":"Zebrafish xenograft model of human lung cancer for studying the function of LINC00152 in cell proliferation and invasion","volume":"20","author":"Shen","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.biopha.2023.114633_bib19","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/jn\/113.9.1737","article-title":"Hypervitaminosis A in rainbow trout (Salmo gairdneri): toxicity signs and maximum tolerable level","volume":"113","author":"Hilton","year":"1983","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2023.114633_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10495-009-0432-9","article-title":"The zebrafish as a model organism for the study of apoptosis","volume":"15","author":"Eimon","year":"2010","journal-title":"Apoptosis: Int. J. Program. Cell death"},{"issue":"10","key":"10.1016\/j.biopha.2023.114633_bib21","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/17460441.2013.825244","article-title":"Use of zebrafish apoptosis assays for preclinical drug discovery","volume":"8","author":"McGrath","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"issue":"4","key":"10.1016\/j.biopha.2023.114633_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103086","article-title":"Ultrasound-assisted extraction of four groups of Osmanthus fragrans fruit: optimization, UPLC-Orbitrap-MS\/MS characterization and anti-inflammatory activity evaluation","volume":"14","author":"Tang","year":"2021","journal-title":"Arab. J. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2023.114633_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11122331","article-title":"Preparation and characterization of ginger peel polysaccharide-Zn (II) complexes and evaluation of anti-inflammatory activity","volume":"11","author":"Li","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.biopha.2023.114633_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/13880209.2016.1238949","article-title":"Meisoindigo, but not its core chemical structure indirubin, inhibits zebrafish interstitial leukocyte chemotactic migration","volume":"55","author":"Ye","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2023.114633_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.152916","article-title":"Triclosan induced zebrafish immunotoxicity by targeting miR-19a and its gene socs3b to activate IL-6\/STAT3 signaling pathway","volume":"815","author":"Zhao","year":"2022","journal-title":"Sci. Total Environ."},{"issue":"3","key":"10.1016\/j.biopha.2023.114633_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.20161525","article-title":"EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay","volume":"214","author":"Volpi","year":"2017","journal-title":"J. Exp. Med"},{"issue":"21","key":"10.1016\/j.biopha.2023.114633_bib27","first-page":"5214","article-title":"Thymosin alpha 1 down-regulates the growth of human non-small cell lung cancer cells in vitro and in vivo","volume":"53","author":"Moody","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2023.114633_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1196\/annals.1415.040","article-title":"Thymosin alpha1 as a chemopreventive agent in lung and breast cancer","volume":"1112","author":"Moody","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.114633_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3835(00)00405-5","article-title":"Thymosinalpha1 is chemopreventive for lung adenoma formation in A\/J mice","volume":"155","author":"Moody","year":"2000","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.biopha.2023.114633_bib30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/tox.22765","article-title":"Thymosin alpha-1; a natural peptide inhibits cellular proliferation, cell migration, the level of reactive oxygen species and promotes the activity of antioxidant enzymes in human lung epithelial adenocarcinoma cell line (A549)","volume":"34","author":"Kharazmi-Khorassani","year":"2019","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114633_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbrc.2015.06.132","article-title":"Thymosin \u03b11 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1","volume":"464","author":"Yuan","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.114633_bib32","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.2147\/OTT.S177943","article-title":"Thymosin \u03b11 suppresses migration and invasion of PD-L1 high-expressing non-small-cell lung cancer cells via inhibition of STAT3-MMP2 signaling","volume":"11","author":"Bo","year":"2018","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.114633_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-020-01587-7","article-title":"Thymosin beta 10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K\/Akt pathway in lung adenocarcinoma","volume":"21","author":"Zeng","year":"2020","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.114633_bib34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1521-4141(200003)30:3<778::AID-IMMU778>3.0.CO;2-I","article-title":"Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level","volume":"30","author":"Giuliani","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114633_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5501\/wjv.v9.i5.67","article-title":"Thymosin alpha 1: a comprehensive review of the literature","volume":"9","author":"Dominari","year":"2020","journal-title":"World J. Virol."},{"key":"10.1016\/j.biopha.2023.114633_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fsi.2019.01.040","article-title":"Thymosin participates in antimicrobial immunity in zebrafish","volume":"87","author":"Zou","year":"2019","journal-title":"Fish. Shellfish Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2023.114633_bib37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/tox.22765","article-title":"Thymosin alpha-1; a natural peptide inhibits cellular proliferation, cell migration, the level of reactive oxygen species and promotes the activity of antioxidant enzymes in human lung epithelial adenocarcinoma cell line (A549)","volume":"34","author":"Kharazmi-Khorassani","year":"2019","journal-title":"Environ. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114633_bib38","first-page":"2611","article-title":"Antitumor and immunomodulatory effects of thymosin against tumor growth in mice","volume":"33","author":"Othman","year":"2020","journal-title":"Pak. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.114633_bib39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00205574","article-title":"Modulation of natural killer activity by thymosin alpha 1 and interferon","volume":"20","author":"Favalli","year":"1985","journal-title":"Cancer Immunol., Immunother.: CII"},{"issue":"3","key":"10.1016\/j.biopha.2023.114633_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2023.114633_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12929-017-0317-0","article-title":"Escape from IFN-\u03b3-dependent immunosurveillance in tumorigenesis","volume":"24","author":"Lin","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2023.114633_bib42","article-title":"Thymosin alpha-1 blocks the accumulation of myeloid suppressor cells in NSCLC by inhibiting VEGF production","volume":"131","author":"Yang","year":"2020","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"10.1016\/j.biopha.2023.114633_bib43","article-title":"Thymosin alpha1: an endogenous regulator of inflammation","volume":"1112","author":"Romani","year":"2007","journal-title":"Immun., Toler., Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.114633_bib44","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2006-02-004762","article-title":"Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance","volume":"108","author":"Romani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2023.114633_bib45","first-page":"154","article-title":"Study of the association between the polymorphism of the TNF-alpha gene and prostate cancer","volume":"66","author":"Pardo","year":"2019"},{"issue":"3","key":"10.1016\/j.biopha.2023.114633_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13273-019-0030-z","article-title":"Ameliorative effect of chlorin e6-mediated photodynamic therapy on DNCB-induced atopic dermatitis-like skin lesions in mice","volume":"15","author":"Ryu","year":"2019","journal-title":"Mol. Cell. Toxicol."},{"issue":"24","key":"10.1016\/j.biopha.2023.114633_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246342","article-title":"Cancer cell-derived granulocyte-macrophage colony-stimulating factor is dispensable for the progression of 4T1 murine breast cancer","volume":"20","author":"Yoshimura","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2023.114633_bib48","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000662","article-title":"Thymosin alpha 1 protects from CTLA-4 intestinal immunopathology","volume":"3","author":"Renga","year":"2020","journal-title":"Life Sci. Alliance"},{"issue":"3","key":"10.1016\/j.biopha.2023.114633_bib49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijrobp.2022.07.009","article-title":"Efficacy of thymosin \u03b11 in management of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy: a phase 2 Clinical Trial (GASTO-1043)","volume":"114","author":"Liu","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.biopha.2023.114633_bib50","article-title":"Effect of thymosin on inflammatory factor levels, immune function, and quality of life in lung cancer patients undergoing radical thoracoscopic surgery","author":"Zhao","year":"2022","journal-title":"Evid. -Based Complement. Altern. Med.: eCAM 2022"},{"key":"10.1016\/j.biopha.2023.114633_bib51","article-title":"The efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitor combined with thymosin in advanced non-small cell lung cancer patients harboring active epidermal growth factor receptor mutations","volume":"11","author":"Feng","year":"2021","journal-title":"Front. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.114633_bib52","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijpharm.2018.06.041","article-title":"Immunomodulatory and enhanced antitumor activity of a modified thymosin \u03b11 in melanoma and lung cancer","author":"Wang","year":"2018","journal-title":"Int. J. Pharm. 547("},{"issue":"1","key":"10.1016\/j.biopha.2023.114633_bib53","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1038\/s41598-018-30956-y","article-title":"Thymosin Alpha1-Fc modulates the immune system and down-regulates the progression of melanoma and breast cancer with a prolonged half-life","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223004213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223004213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:22:38Z","timestamp":1778246558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223004213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":53,"alternative-id":["S0753332223004213"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114633","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic anti-cancer and attenuation effects of thymosin on chemotherapeutic drug vinorelbine in tumor-bearing zebrafish","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114633"}}